JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2016, 65(2):43-51 | DOI: 10.36290/csf.2016.010

Potential immunomodulatory and antiinflammatory mechanisms of probiotics

Andrea Bilková*, František Bilka, Hana Kiňová Sepová
Katedra bunkovej a molekulárnej biológie liečiv, Farmaceutická fakulta, Univerzita Komenského v Bratislave

The number of preclinical and clinical studies showing efficacy of probiotics in the treatment and prophylaxis of certain diseases, e.g. diarrhoea of various origin, irritable bowel syndrome, inflammatory bowel disease, allergies, hypercholesterolemia, bacterial vaginosis, and colorectal cancer, is increasing. These health benefits are often species and strain specific. This article provides an overview of available knowledge about the supposed mechanisms of probiotic microorganism's action focusing in particular on the interaction between probiotic and host cells. One of the results of this interaction is induction of pro- or anti-inflammatory immune response in the macroorganism. Detailed knowledge of the signalling pathways involved in the communication between bacterial and human cells can find application in the selection of optimal probiotics for the targeted treatment of selected diseases. Additional possibilities for their use in clinical practice are provided by genetic manipulation of probiotic microorganisms.

Keywords: probiotics; inflammation; signalling pathways; immunomodulation; genetic manipulation
Grants and funding:

Práca bola podporená aj grantom APVV 0484-12.

Received: November 25, 2015; Accepted: April 1, 2016; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bilková A, Bilka F, Kiňová Sepová H. Potential immunomodulatory and antiinflammatory mechanisms of probiotics. Čes. slov. farm. 2016;65(2):43-51. doi: 10.36290/csf.2016.010.
Download citation

References

  1. Pot B., Tsakalidou E. Taxonomy and metabolism of Lactobacillus. In: Ljung Å., Wadström T. (eds.) Lactobacillus molecular biology. From genomics to probiotics. 1st ed. Norfolk: Caister Academic Press 2009.
  2. Grover S., Rashmi H. M., Srivastava A. K., Batish V. K. Probiotics for human health - new innovations and emerging trends. Gut Pathogens 2012; 4, 1. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544614/ (12. 11. 2015) Go to original source... Go to PubMed...
  3. Foligné B., Daniel C., Pot B. Probiotics from research to market: the possibilities risks and challenges. Curr. Opin. Microbiol. 2013; 16, 284-292. Go to original source... Go to PubMed...
  4. Nissle A. Explanations of the significance of colonic dysbacteria the mechanism of action of E. coli therapy (mutaflor). Medizinische 1959; 4, 1017-1022.
  5. Behnsen J., Deriu E., Sassone-Corsi M., Raffatellu M. Probiotics: Properties, examples, and specific applications. Cold Spring Harb. Perspect. Med. 2013; 3, a010074. Go to original source... Go to PubMed...
  6. Khatri I., Akhtar A., Kaur K., Tomar R., Prasad G. S., Ramya T. N., Subramanian S. Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii. Gut Pathog. 2013; 5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843575/ (12. 11. 2015) Go to original source... Go to PubMed...
  7. Lebeer S., Vanderleyden J., De Keersmaecker S. C. J. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008; 72, 728-764. Go to original source... Go to PubMed...
  8. Kiňová Sepová H., Bilková A., Bilka F., Bezáková L. Antimikróbne pôsobiace látky produkované baktériami mliečneho kvasenia. Čes. slov. Farm. 2010; 59, 155-159.
  9. Hevia A., Delgado S., Sánchez B., Margolles A. Molecular players involved in the interaction between beneficial bacteria and the immune system. Front. Microbiol. 2015; 6, 1285. Go to original source... Go to PubMed...
  10. Kang H.-J., Im S.-H. Probiotics as an immune modulator. J. Nutr. Sci. Vitaminol. 2015; 61, S103-S105. Go to original source... Go to PubMed...
  11. Bilková A., Kiňová Sepová H., Bilka F., Balažová A. Bakteriocíny produkované baktériami mliečneho kvasenia. Čes. slov. Farm. 2011; 60, 65-72.
  12. Nagpal R., Behare P. V., Kumar M., Mohania D., Yadav M., Jain S., Menon S., Parkash O., Marotta F., Minelli E., Henry C. J., Yadav H. Milk, milk products and disease free health: an updated overview. Crit. Rev. Food Sci. Nutr. 2012; 52, 321-333. Go to original source... Go to PubMed...
  13. Bested A. C., Logan A. C., Selhub E. M. Intestinal microbiota, probiotics and mantal health: from Metchnikoff to modern advances: Part II - contemporary contextual research. Gut Pathogens 2013; 5, 1-14. Go to original source... Go to PubMed...
  14. Karpiňski T. M., Szkaradkiewicz A. K. Characteristic of bacteriocines and their application. Pol. J. Bacteriol. 2013; 62, 223-235. Go to original source...
  15. Kayserová H. Potravinová alergia. Via Practica 2004; 2, 90-94.
  16. Lebeer S., Vanderleyden J., De Keersmaecker S. C. J. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Microbiol. 2010; 8, 171-184. Go to original source... Go to PubMed...
  17. Sellge G., Kufer T. A. PRR-signaling pathways: learning from microbial tactics. Semin. Immunol. 2015; 27, 75-84. Go to original source... Go to PubMed...
  18. O'Hara A. M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006; 7, 688-693. Go to original source... Go to PubMed...
  19. Thomas C. M., Versalovic J. Probiotics-host communication. Modulation of signaling pathways in the intestine. Gut Microbes 2010; 1, 148-163. Go to original source... Go to PubMed...
  20. Tiptiri-Kourpeti A., Spyridopoulou K., Santarmaki V., Aindelis G., Tompoulidou E., Laprianidou E. E., Saxami G., Ypsilantis P., Lampri E. S., Simopoulos C., Kotsianidis I., Galanis A., Kourkoutas Y., Dimitrellou D., Chlichlia K. Lactobacillus casei exerts anti-proliferative effects accompanied by apoptoticcell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One 2016; 11: e0147960. Go to original source... Go to PubMed...
  21. Sengupta R., Altermann E., Anderson E., Anderson R. C., McNabb W. C., Moughan P.J., Roy N. C. The role of cell surface architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract. Med. Inflamm. 2013; 237921, doi:10.1155/2013/237921 Go to original source... Go to PubMed...
  22. Mohamadzadeha M., Pfeiler E. A., Brown J. B., Zadeha M., Gramarossa M., Managlia E., Berea P., Sarraj B., Khan M. W., Pakanati K. Ch., Ansari M. J., O'Flaherty S., Barrett T., Klaenhammer T. R. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. PNAS 2011; 108, 4623-4630. Go to original source... Go to PubMed...
  23. Meshkibaf Sh., Fritz J., Gottschalk M., Kim S. O. Preferential production of G-CSF by a protein-like Lactobacillus rhamnosus GR-1 secretory factor through activating TLR2-dependent signaling events without activation of JNKs. BMC Microbiol. 2015; 15, doi:10.1186/s12866-015-0578-2. Go to original source... Go to PubMed...
  24. Schiffrin E. J., Blum S. Interaction between the microbiota and the intestinal mucosa. Eur. J. Clin. Nutr. 2002; 56, 60-64. Go to original source... Go to PubMed...
  25. Yousefi M., Movassaghpour A. A., Shamsasenjan K., Ghalamfarsa G., Sadreddini S., Jadidi-Niaragh F. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. Future Oncol. 2015; 11, 1567-1582. Go to original source... Go to PubMed...
  26. Nyirenda M. H., Morandi E., Vinkemeier U., Constantin - Teodosiu D., Drinkwater S., Mee M. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis. J. Immunol. 2015; 194, 5761-5774. Go to original source... Go to PubMed...
  27. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003; 21, 335-376. Go to original source... Go to PubMed...
  28. Yoon S. I., Kurnasov O., Natarajan V., Hong M., Gudkov A. V., Osterman A. L., Wilson I. A. Structural basis of TLR5-flagellin recognition and signaling. Science 2012; 17, 859-864. Go to original source... Go to PubMed...
  29. Park B. S., Lee J.-O. Recognition of lipopolysacharide pattern by TLR4 complexes. Exp. Mol. Med. 2013; 45, e66. Go to original source... Go to PubMed...
  30. Dambuza I. M., Brown G. D. C-type lectins in imunity: recent developments. Curr. Opin. Immunol. 2015; 32, 21-27. Go to original source... Go to PubMed...
  31. Claes A. K., Zhou J. Y., Philpott D. J. NOD-like receptors: guardians of intestinal mucosal barriers. Physiology (Bethesda) 2015; 30, 241-250. Go to original source... Go to PubMed...
  32. Liu H.-Y., Roos S., Jonsson H., Ahl D., Dicksved J., Lindberg J. E. Lundh T. Effects of Lactobacillus johnsonii and Lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. Physiol. Rep. 2015; 3, e12355. Go to original source... Go to PubMed...
  33. Koboziev I., Karlsson F., Grisham M. B. Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Ann. N. Y. Acad. Sci. 2010; 1207, 86-93. Go to original source... Go to PubMed...
  34. Demeria D., Ewaschuk J., Madsen K. Interactions of Lactobacillus with the immune system. In: Ljung Å., Wadström T. (eds.) Lactobacillus molecular biology. From genomics to probiotics. 1st ed. Norfolk: Caister Academic Press 2009.
  35. Mileti E., Matteoli G., Iliev I. D., Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009; 4, e7056. Go to original source... Go to PubMed...
  36. Caselli M., Cassol F., Caló G., Holton J., Zuliani G., Gasbarrini A. Actual concept of "probiotics": Is it more functional to science or business? World J. Gastroenterol. 2013; 19, 1527-1540. Go to original source... Go to PubMed...
  37. Bassaganya-Riera J., Viladomiu M., Pedragosa M., De Simone C., Carbo A., Shaykhutdinov R., Jobin Ch., Arthur J. C., Corl B. A., Vogel H., Storr M., Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPARγ to suppress colitis. PLoS One 2012; 7, e31238. Go to original source... Go to PubMed...
  38. Jijon H., Backer J., Diaz H., Yeung H., Thiel D., McKaigney C., De Simone C., Madsen K. DNA from probiotic bacteria modulates murine and human epitelial and immune function. Gastroenterol. 2004; 126, 1358-1373. Go to original source... Go to PubMed...
  39. Resta-Lenert S, Barrett K. E. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterol. 2006; 130, 731-746. Go to original source... Go to PubMed...
  40. Sakai F., Hosoya T., Ono-Ohmachi A., Ukibe K., Ogawa A., Moriya T., Kadooka Y., Shiozaki T., Nakagawa H., Nakayama Y., Miyazaki T. Lactobacillus gasseri SBT2055 induces TGF-βα expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLoS One 2014; 9, e105370. Go to original source... Go to PubMed...
  41. De Kivit S., Tobin M. C., Forsyth C. B., Keshavarzian A., Landay A. Regulation of intestinal immune responses through TLR activation: implication for pro- and prebiotics. Front. Microbiol. 2014; 5, 1-7. Go to original source... Go to PubMed...
  42. Galdeano C. M., Perdigón G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate imunity. Clin. Vaccine Immunol. 2006; 13, 219-226. Go to original source... Go to PubMed...
  43. Smits H. H., Engering D., van der Kleij E. C., de Jong K., Schipper T. M. M., van Capel B. A., Zaat M. Selective probiotic bacteria induce IL-10-producing regulatory cells in vitro by modulating dendritic cell 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005; 115, 1260-1267. Go to original source... Go to PubMed...
  44. Viljanen M., Pohjavuori E., Haahtela T., Korpela R. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 2005; 115, 1254-1259. Go to original source... Go to PubMed...
  45. Guarino A., Lo Vecchio A., Canani R. B. Probiotics as prevention and treatment for diarhea. Curr. Opin. Gastroenterol. 2009; 25, 18-23. Go to original source... Go to PubMed...
  46. Zhang L., Li N., Caicedo R., Neu J. Alive and died Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells. J. Nutr. 2005; 135, 1752-1756. Go to original source... Go to PubMed...
  47. Tien M. T., Girardin S. E., Regnault B., Le Bourhis L., Dillies M. A., Coppee J. Y. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epitelial cells. J. Immunol. 2006; 176, 1228-1237. Go to original source... Go to PubMed...
  48. Frick J. S., Schenk K., Quitadamo M., Kahl F., Koberle M., Bohn E. Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm. Bowel Dis. 2007; 13, 83-90. Go to original source... Go to PubMed...
  49. Ruiz P. A., Hoffmann M., Szcesny S., Blaut M., Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses to intestinal epithelial cells after the colonization of germ-free rats. Immunology 2005; 115, 444-450. Go to original source... Go to PubMed...
  50. Gourbeyre P., Denery S., Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J. Leuko. Biol. 2011; 89, 685-694. Go to original source... Go to PubMed...
  51. Pelto L., Isolauri E., Lilius E. M., Nuutila J., Salminen S. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 1998; 28, 1474-1479. Go to original source... Go to PubMed...
  52. Aimutis W. R. Biology of Lactobacillus acidophilus. In: Batt C. A., Tortorello M.-L. (eds.) Encyclopedia of food microbiology. 2nd ed. London: Elsevier Ltd., Academic Press 2014.
  53. Marin M. L., Lee J. H., Murtha J., Ustunol Z., Pestka J. J. Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 1997; 80, 2713-2720. Go to original source... Go to PubMed...
  54. Herbel S. R., Vahjen W., Wieler L. H., Guenther S. Timely approaches to identify probiotic species of the genus Lactobacillus. Gut Pathogens 2013; 5, 27. Go to original source... Go to PubMed...
  55. Iliev I. D., Tohno M., Kurosaki D., Shimosato T., He F., Hosoda M., Saito T., Kitazawa H. Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice. Scand. J. Immunol. 2008; 67, 370-376. Go to original source... Go to PubMed...
  56. Tlaskalová-Hogenová H., Štepanková R., Kozáková H., Hudcovič T., Vannucci L., Tučková L., Rossmann P., Hrnčiř T., Kverka M., Zakostelská Z., Klimešová K., Přibylová J., Bártová J., Sanchez D., Fundová P., Borovská D., Srůtková D., Zídek Z., Schwarzer M., Drastich P., Funda D. P. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer. Contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol. Immunol. 2011; 8, 110-120. Go to original source... Go to PubMed...
  57. Kamada N., Núnez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146, 1477-1488. Go to original source... Go to PubMed...
  58. Aureli P., Capurso L., Castellazzi A. M., Clerici M., Giovannii M., Morelli L., Poli A., Pregliasco F., Salvini F., Zuccotti G. V. Probiotics and health: An evidence based review. Pharmacol. Res. 2011; 63, 366-376. Go to original source... Go to PubMed...
  59. Bermúdez-Humarán L. G., Aubry C., Motta J. P., Deraison C., Steidler L., Vergnolle N., Chatel J. M., Langella P. Engeneering lactococci and lactobacilli for human health. Curr. Opinion Microbiol. 2013; 16, 278-283. Go to original source... Go to PubMed...
  60. Cano-Garrido O., Seraz-Franzoso J., Garcia-Fruitós E. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb. Cell Fact. 2015; 14, 137. Go to original source... Go to PubMed...
  61. Braat H., Rottiers P., Hommers D. W., Huyghebaert N., Remaut E., Remon J. P., van Deventer S. J., Neirynck S., Peppelenbosch M. P., Steidler L. A phase 1 trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 2006; 4, 754-759. Go to original source... Go to PubMed...
  62. Vandenbroucke K., Haard H., Beinaert E., Dreier T., Lauwereys M., Huyck L., Van Huysse J., Demetter P., Steidler L., Reumaut E. Orally administered L. lactis secreting an anti-TNF nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 2010; 3, 49-56. Go to original source... Go to PubMed...
  63. Vijayan V., Mueller S., Baumgart-Vogt E., Immenschuh S. Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J. Gastroenterol. 2010; 16, 3112-3119. Go to original source... Go to PubMed...
  64. Caluwaerts S., Vandenbroucke K., Steidler L., Neirynck S., Vanhoenacker P., Corveleyn S., Watkins B., Sonis S., Coulie B., Rotters P. AG013, a mouth rinse formulation of Lactococcus lactis sectering human Trefoil Factor 1, provides a safe an efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 2010; 46, 564-570. Go to original source... Go to PubMed...
  65. Motta J. P., Magne L., Descamps D., Rolland C., Squarzoni-Dale C., Rosset P., Martin L., Cenac N., Balloy V., Huerre M. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterol. 2011; 140, 1272-1282. Go to original source... Go to PubMed...
  66. Motta J. P., Bermúdez-Humarán L. G., Deraison C., Martin L., Rolland C., Rousset P., Boue J., Dietrich G., Chapman K., Kharrat P. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med. 2012; 4, 144-158. Go to original source... Go to PubMed...
  67. Bernstein C. N. Treatment of IBD: where we are and where we are going. Am. J. Gastroenterol. 2015; 110, 114-126. Go to original source... Go to PubMed...
  68. Shaw L., Wiedow O. Therapeutic potential of human elafin. Biochem. Soc. Trans. 2011; 39, 1450-1454. Go to original source... Go to PubMed...
  69. Carroll I. M., Andrus J. M., Bruno-Barcena J. M., Klaenhammer T. R., Hassan H. M., Threadgill D. S. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293, G729-G738. Go to original source... Go to PubMed...
  70. Watterlot L., Rochat T., Sokol H., Cherbuy C., Bouloufa I., Lefevre F., Gratadoux J. J., Honvo-Hueto E., Chilmonczyk S., Blugeon S. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int. J. Food Microbiol. 2010; 144, 35-41. Go to original source... Go to PubMed...
  71. LeBlanc J. G., del Carmen S., Miyoshi A., Azevedo V., Sesma F., Langella P., Bermúdez-Humarán L. G., Watterlot L., Perdigon G., LeBlanc A. D. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J. Biotechnol. 2011; 151, 287-293. Go to original source... Go to PubMed...
  72. Ljungh A., Wadström T. From probiotics, prebiotics and symbiotics to "living drugs". In: Ljungh Å., Wadström T. eds. Lactobacillus molecular biology: From genomics to probiotics. 1st ed. Norfolk: Caister Academic Press 2009.
  73. LeBlanc J. G., Aubry C., Cortes-Perez N. G., Dde Moreno de LeBlanc A., Vergnolle N., Langella P., Azevedo V., Chatel J. M., Miyoshi A., Bermudez-Humaran L. G. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol. Lett. 2013; 344, 1-9. Go to original source... Go to PubMed...
  74. Bermudez-Humaran L. G., Motta J. P., Aubry C., Kharrat P., Rous-Martin L., Sellenave J. M., Deraison C., Vergnolle N., Langella P. Serine protease inhibitors protect better than IL-10 and TGF-beta anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb. Cell Fact. 2015 Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.